Ziegler Capital Management, LLC Chinook Therapeutics, Inc. Transaction History

Ziegler Capital Management, LLC

  • $2.84 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023
BUY
$21.53 - $26.8 $5,576 - $6,941
259 Added 0.98%
26,725 $618,000
Q4 2022

Jan 24, 2023
BUY
$18.63 - $27.35 $12,780 - $18,762
686 Added 2.66%
26,466 $0
Q3 2022

Oct 25, 2022
BUY
$17.51 - $23.37 $451,407 - $602,478
25,780 New
25,780 $507,000

Others Institutions Holding KDNY

# of Institutions
5
Shares Held
234K
Call Options Held
0
Put Options Held
0
View Full List

About CHINOOK THERAPEUTICS, INC.

KDNY Quotes by TradingView
  • Ticker KDNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,896,300
  • Description
  • Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...
More about KDNY
Track This Portfolio

Track Ziegler Capital Management, LLC Portfolio

Follow Ziegler Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ziegler Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email